Maintaining a Hold: AlloVir's Strategic Uncertainty and Financial Outlook
TipRanksMar 19 01:35 ET
ALLOVIR SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $25,000 investing in AlloVir stock or options between March 22, 2022 and December 21, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson
GlobeNewswireFeb 23 10:30 ET
AlloVir Faces Delisting Risk, Considers Reverse Split to Comply
TipRanksFeb 12 16:43 ET
AlloVir(ALVR.US) Officer Sells US$7,493.92 in Common Stocks
$AlloVir(ALVR.US)$ Officer Hagen Brett R sold 11,150 shares of Common Stocks on Feb 8, 2024 at an average price of $0.6721 for a total value of $7,493.92.Source: Announcement What is statement of chan
moomoo NewsFeb 9 20:43 ET
Top 4 Health Care Stocks That May Rocket Higher In Q1
The most oversold stocks in the health care presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to i
BenzingaJan 16 06:50 ET
AlloVir To Cut 95% of Workforce After Discontinuing Trials
By Ben Glickman AlloVir will cut about 95% of its current employee base after scrapping three late-stage clinical trials. The cell-therapy developer said in a regulatory filing Thursday that the lay
WSJJan 4 18:00 ET
On January 1, 2024, AlloVir Board Approved Reduction Its Workforce By Approximately 95% Of Current Employee Base To Reduce Costs And Preserve Capital - Filing
The move follows AlloVir's announcement on December 22, 2023 that it is discontinuing its three global Phase 3 posoleucel studies. This workforce reduction will take place primarily during the first q
BenzingaJan 4 17:27 ET
AlloVir(ALVR.US) Officer Sells US$20,837.56 in Common Stocks
$AlloVir(ALVR.US)$ Officer Hagen Brett R sold 28,335 shares of Common Stocks on Dec 27, 2023 at an average price of $0.7354 for a total value of $20,837.56.Source: Announcement What is statement of ch
moomoo NewsJan 2 19:49 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Karuna Therapeutics (KRTX), AlloVir (ALVR) and Top Glove Bhd (OtherTGLVY)
TipRanksDec 29, 2023 07:10 ET
We're Keeping An Eye On AlloVir's (NASDAQ:ALVR) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring reve
Simply Wall StDec 28, 2023 07:47 ET
AlloVir Downgraded to Equal Weight at Morgan Stanley
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
MarketWatchDec 26, 2023 10:32 ET
Cognizant Technology Solutions To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwri
BenzingaDec 26, 2023 08:03 ET
AlloVir Cut to Underperform From Buy by B of A Securities
AlloVir Cut to Underperform From Buy by B of A Securities
Dow JonesDec 26, 2023 07:05 ET
B of A Securities Downgrades AlloVir to Underperform, Lowers Price Target to $1
B of A Securities analyst Jason Zemansky downgrades AlloVir (NASDAQ:ALVR) from Buy to Underperform and lowers the price target from $17 to $1.
BenzingaDec 26, 2023 06:56 ET
AlloVir Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/26/2023 30.07% B of A Securities $17 → $1 Downgrades Buy → Underperform 12/22/2023 30.07% Leerink Partn
BenzingaDec 26, 2023 06:54 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Sarepta Therapeutics (SRPT), AlloVir (ALVR) and Bristol-Myers Squibb (BMY)
TipRanksDec 26, 2023 06:41 ET
Trending Stocks Today: NextPlay Technologies Surges 201.65%
December 25th - US stocks trending in regular trading hours.Gainers: $NextPlay Technologies(NXTP.US)$ soars 201.65% to $2.73 with a turnover of $257.87 million. $Esports Entertainment Group(GMBL.US)$
moomoo NewsDec 25, 2023 14:00 ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersKaruna Therapeutics (NASDAQ:KRTX) shares increased by 47.4% to $317.1 during Monday's pre-market session. The company's market cap stands at $11.9 billion. Universe Pharmaceuticals (NASDAQ:UPC)
BenzingaDec 25, 2023 08:05 ET
U.S. Shares Mixed at Close of Trade; Dow Jones Industrial Average Down 0.05%
InvestingDec 22, 2023 16:30 ET
Sector Update: Health Care Stocks Gain in Late Afternoon
Health care stocks rose late Friday afternoon with the NYSE Health Care Index adding 0.3% and the Health Care Select Sector SPDR Fund (XLV) up 0.4%. The iShares Biotechnology ETF (IBB) rose 2.2%. In c
MT NewswiresDec 22, 2023 15:50 ET
No Data
No Data